SageView Advisory Group’s AbbVie ABBV Stock Holding History

SageView Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$7.68M	Sell	33,628 -2,679	-7%	-$610K	0.26%	47
2025 Q3	$8.41M	Buy	36,307 +13,883	+62%	+$2.83M	0.29%	42
2025 Q2	$4.23M	Buy	22,424 +4,020	+22%	+$747K	0.16%	74
2025 Q1	$3.86M	Buy	18,404 +474	+3%	+$92.1K	0.16%	69
2024 Q4	$3.19M	Buy	17,930 +5,327	+42%	+$979K	0.14%	83
2024 Q3	$2.49M	Sell	12,603 -5,862	-32%	-$1.09M	0.13%	98
2024 Q2	$3.17M	Buy	18,465 +3,935	+27%	+$652K	0.15%	85
2024 Q1	$2.65M	Sell	14,530 -7,768	-35%	-$1.34M	0.13%	90
2023 Q4	$3.68M	Buy	22,298 +9,460	+74%	+$1.38M	0.16%	80
2023 Q3	$1.91M	Sell	12,838 -188	-1%	-$27.6K	0.11%	116
2023 Q2	$1.75M	Sell	13,026 -242	-2%	-$35.5K	0.1%	127
2023 Q1	$2.11M	Buy	13,268 +3,142	+31%	+$480K	0.13%	109
2022 Q4	$1.64M	Buy	+10,126	New	+$1.55M	0.13%	108

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SageView Advisory Group's ABBV Position: Q4 2025 in Review

SageView Advisory Group reduced its AbbVie (ABBV) stake by 7.4% in Q4 2025, selling an estimated $610K and leaving 33,628 shares worth $7.68M. The position accounts for 0.26% of the portfolio, ranked #47.

SageView Advisory Group first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $8.41M in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

SageView Advisory Group held 33,628 shares of AbbVie worth $7.68M as of Q4 2025.
SageView Advisory Group sold 2,679 AbbVie shares in Q4 2025, an estimated $610K.
AbbVie made up 0.26% of SageView Advisory Group's portfolio in Q4 2025, its #47 holding.
SageView Advisory Group first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
SageView Advisory Group's AbbVie position peaked at $8.41M in Q3 2025.
4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.